Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Neuropharmacology. 2013 Aug 2;0:10.1016/j.neuropharm.2013.07.019. doi: 10.1016/j.neuropharm.2013.07.019

Figure 2.

Figure 2

Panel A shows mean (±SEM) lever presses during nicotine self-administration phase (*significantly different from inactive lever; inset graph shows total infusions earned during the session). Panel B shows mean (±SEM) lever presses during iptakalim dose-response tests (*significantly different from 0 mg/kg active lever responding). Panel C shows mean (±SEM) chamber crosses during the iptakalim dose-response tests (*significantly different from 0 mg/kg; p<0.05).